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Abstract
Background: Exposure to aerosols from metalworking fluids (MWF) has previously been related to a series of adverse health
outcomes (eg, cancer, respiratory diseases). Our present epidemiological study focuses on occupational exposures to MWF and
a panel of exposure and effect biomarkers. We hypothesize that these health outcomes are caused by particle exposure that
generates oxidative stress, leading to airway inflammation and ultimately to chronic respiratory diseases. We aimed to assess
whether MWF exposure, in particular as characterized by its oxidative potential, is associated with biomarkers of oxidative stress
and inflammation as well as genotoxic effects.
Objective: The ultimate goal is to develop exposure reduction strategies based on exposure determinants that best predict
MWF-related health outcomes. The following relationships will be explored: (1) exposure determinants and measured exposure;
(2) occupational exposure and preclinical and clinical effect markers; (3) exposure biomarkers and biomarkers of effect in both
exhaled breath condensate and urine; and (4) biomarkers of effect, genotoxic effects and respiratory symptoms.
Methods: At least 90 workers from France and Switzerland (30 controls, 30 exposed to straight MWF and 30 to aqueous MWF)
were followed over three consecutive days after a nonexposed period of at least two days. The exposure assessment is based on
MWF, metal, aldehyde, and ultrafine particle number concentrations, as well as the intrinsic oxidative potential of aerosols.
Furthermore, exposure biomarkers such as metals, metabolites of polycyclic aromatic hydrocarbons and nitrosamine are measured
in exhaled breath condensate and urine. Oxidative stress biomarkers (malondialdehyde, 8-isoprostane, 8-hydroxy-2’-deoxyguanosine,
nitrates, and nitrites) and exhaled nitric oxide, an airway inflammation marker, are repeatedly measured in exhaled breath
condensate and urine. Genotoxic effects are assessed using the buccal micronucleus cytome assay. The statistical analyses will
include modelling exposure as a function of exposure determinants, modelling the evolution of the biomarkers of exposure and
effect as a function of the measured exposure, and modelling respiratory symptoms and genotoxic effects as a function of the
assessed long-term exposure.
Results: Data collection, which occurred from January 2018 until June 2019, included 20 companies. At the date of writing,
the study included 100 subjects and 29 nonoccupationally exposed controls.
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Conclusions: This study is unique as it comprises human biological samples, questionnaires, and MWF exposure measurement.
The biomarkers collected in our study are all noninvasive and are useful in monitoring MWF exposed workers. The aim is to
develop preventative strategies based on exposure determinants related to health outcomes.
International Registered Report Identifier (IRRID): DERR1-10.2196/13744
(JMIR Res Protoc 2019;8(8):e13744)  doi: 10.2196/13744
KEYWORDS
metalworking fluid; oxidative stress; exposure biomarkers; early effect biomarkers; genotoxic effects; occupational epidemiology
Introduction
Metalworking Fluids and Their Aerosols
Metalworking fluids (MWF) are used to lubricate and cool tools
and the workpiece, as well as flush away metal chips during
machining, cutting, grinding, and drilling of metals in many
manufacturing processes, from small parts in the watch-making
industry to large parts in the automotive or steel industries.
MWF are classified into two main families [1]: (1) Straight
MWF that is mineral oil containing no water; and (2) Aqueous
MWF that regroup so-called soluble oils and semisynthetic
fluids according to the amount of mineral oils emulsified in
water, as well as synthetic fluids that contain no mineral oil.
Depending on their type and use, MWF may contain lubricity,
antimisting or antiwear additives, corrosion inhibitors and
biocides, as well as perfumes or coloring agents.
Other substances potentially present in the aerosols from used
MWF are the result of thermal degradation or contamination of
the machined metal parts. Thus, MWF may contain: (1)
polycyclic aromatic hydrocarbons (PAHs) due to lack of an
initial refining stage or due to thermal degradation; (2)
nitrosamines, present in aqueous MWF as by-products of the
reaction between secondary amines and nitrite; or (3)
microorganisms like bacteria or mycobacteria that may be
growing in tanks containing aqueous MWF.
The physical process of metalworking generates a complex
MWF aerosol consisting of droplets (the oil mist), which may
contain solid particles (eg, metals), and a vapor phase (air or
organic vapors). This vapor phase is the result of the evaporation
of volatile or semivolatile constituents from the MWF in contact
with the hot cutting zone. These aerosols can reach the workers’
breathing zone and may remain in suspension for several hours
[1]. The size distribution of the MWF aerosols is highly variable
(median aerodynamic diameters ranging from 1.8-17 µm) and
may contain ultrafine particles (aerodynamic diameter <0.1µm)
[2]. MWF aerosols may be inhaled or enter the body through
skin contact. Exposure from soiled clothing and ingestion (hand
to mouth contamination) are also possible. Consequently,
assessing occupational exposure to MWF aerosols has many
challenges.
Health Effects From Exposure to Metalworking Fluids
Historically, exposure to poorly refined straight oil-mists has
been related to cancer of the skin and the scrotum [3]. More
recently, there is growing evidence of a relationship between
exposure to straight MWF and bladder cancer [4,5]. As early
as the 1990s, exposure to oil-mist was related to acute bronchial
hyperresponsiveness, occupational asthma, hypersensitivity
pneumonitis, ventilatory impairments and respiratory symptoms
[6-9]. Recently, a causal model was applied [10] to explore the
quantitative relationship between exposure to MWF aerosol
and chronic obstructive pulmonary disease (COPD).
Presumed Physiopathological Mechanisms
Inflammation is hypothesized to be an important process that
explains some of the observed health outcomes. Indeed, in vivo
chronic exposure to rather high concentrations of different
semisynthetic MWF have resulted in inflammation in rat and
mice lungs [11]. In addition, signs of oxidative stress have also
been reported on the skin of vitamin E deficient mice exposed
to MWF [12]. Based on this, Figure 1 (adapted from Ayres et
al [13] who presented this mechanism for environmental
particulate exposure) summarizes the presumed
physiopathological mechanism. Given the multiplicity of health
outcomes that have been related to oil-mist exposure, we
assumed that the main, common mechanism of these effects
was oxidative stress. Briefly, the exposure to the MWF aerosols
generates free radicals in the lungs of both exogenous and
endogenous origin and thereby causes oxidative stress. This
oxidative stress induces inflammation, which ultimately
increases the oxidative stress via a feedback mechanism. Thus,
this chronic inflammation eventually leads to chronic adverse
health effects.
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Figure 1. Presumed physio-pathological mechanism adapted from Ayres et al. (2008).
Methods
The Study Protocol
The Study Objectives
The study protocol very closely followed the mechanistic
pathway outlined in Figure 1 by proposing an epidemiological
field study in both the Swiss micromechanical industry and the
French metal industry. It assessed the exposure to MWF
approximating the biological effect dose, the oxidative stress,
inflammation, genotoxic cellular modifications, and the early
nonspecific effect biomarkers that might be on the pathways
that lead to chronic respiratory diseases.
The ultimate objective is to develop exposure reduction
strategies based on exposure determinants that best predict
MWF-related health outcomes. This ultimate objective is broken
down into several partial objectives summarized in Figure 2.
The first primary objective of the study, though, was to establish
relationships between the exposure determinants and the
exposure measurements. The second primary objective was to
establish relationships between occupational exposure,
especially oxidative potential, and preclinical and clinical effect
markers. There were also two secondary objectives, which
included establishing relationships between exposure biomarkers
and biomarkers of effect in exhaled breath condensate (EBC)
and Urine, as well as establishing relationships between
biomarkers of effect, genotoxic effects and respiratory
symptoms.
Figure 2. Schematic presentation of the study objectives.
Protocol of the Epidemiological Field Study
A three day long longitudinal study of exposed versus
nonexposed workers, after a nonexposed period of at least two
days, was conducted in Swiss and French companies. At least
30 workers were exposed to straight oil and 30 workers were
exposed to water-based MWF. Nonexposed workers from the
participating companies will be included, at a ratio of 2 exposed
for 1 nonexposed.
The exclusion criteria for this study were: (1) known chronic
or acute respiratory diseases; and (2) known exposure to
particulate substances with a potential effect on oxidative stress.
The data collection is summarized in Figure 3. It will consist
of repeated characterization of airborne exposure during two
consecutive days and multiple collections of EBC, urine and
fractional exhaled nitric oxide (FeNO) in parallel. Buccal cells
will be collected once per participant. A questionnaire that
explores respiratory symptoms, sociodemographic factors
(smoking and clinical history, age, etc), the present job, tasks,
personal protective equipment, and the participant’s job history
will also be applied.
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Figure 3. Schematic presentation of the field study protocol. EBC: exhaled breath condensate; FeNO: fractional exhaled nitric oxide.
EBC will be collected at the beginning of the shift on Day 1
and at the end of Day 2. Urine samples will be collected at the
beginning of shift on Days 1, 2 and 3 as well as at the end of
the shift on Days 1 and 2. The FeNO will be measured at the
beginning and end of shift on Days 1 and 2. The exposure
measurements will be obtained over the shifts of Day 1 and 2.
In addition to these data, the occupational hygienists will record
workers’ tasks and the corresponding exposure determinants.
Finally, samples of both used and new MWF will be obtained.
Exposure and Health Outcome Assessment
Table 1 summarizes the different outcomes measured during
the field study.
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Table 1. Outcomes measured in the field study.
MethodMeasured outcomeOutcome type
QuestionnaireDeterminantsExposure determinants
Exposure measurements
Personal sampling •• Metropol M-282Standard gravimetric exposure
•• Thermal degradation methodOrganic carbon
•• Real time instrumentMeasurement of ultrafine particle numbers
Stationary sampling •• Metropol M-282Standard gravimetric exposure
•• Ferrous oxidation-xylenol orange methodOxidative potential
•• Metropol M4 and M66Aldehydes
• •Metals Metropol M122
•• Thermal degradation methodOrganic carbon
• •NO2– a, NO3– b Ion chromatography
• Real time instrument
• Measurements of ultrafine particle numbers
Monitoring of new and used MWFc •• Ferrous oxidation-xylenol orange assayOxidative potential
•• ICP-AESdMetals
• Organic carbon • Thermal degradation method
• Benzo(a)Pyrene • HPLC-Fluoe
Biomarkers of exposure
In exhaled breath condensate •• Ion chromatographyNO2–/NO3–
• ICP-MSf• Metals
In urine •• HPLC-MS/MShNDELAg
•• HPLC-Fluo1-OHPi, 3-OHBaPj (PAHk metabolites)
• ICP-MS• Metals
Biomarkers of effect
In exhaled breath condensate •• HPLC-MS/MSMDAl, 8-isoprostane (markers of lipid peroxidation)
• HPLC-MS/MS• 8-OHdGm (marker of DNA oxidation)
• Ion chromatography
• Formate, NO2–/NO3– (proposed markers of ni-
trosative stress)
In urine •• HPLC-MS/MSMDA, 8-isoprostane (markers of lipid peroxidation)
•• HPLC-MS/MS8-OHdG (marker of DNA oxidation)
Other effect markers •• Buccal micronucleus cytome assayMicronuclei in buccal cells (marker of genotoxicity)
• •Fractional Exhaled Nitric Oxide (marker of
eosinophilic inflammation)
Direct-reading instrument
• Standardized questionnaire
• Respiratory symptoms
aNO2–: nitrite
bNO3–: nitrate
cMWF: metalworking fluids
dICP-AES: inductively coupled plasma atomic emission spectroscopy
eHPLC-Fluo: high-performance liquid chromatography with fluorescence detection
fICP-MS: inductively coupled plasma mass spectrometer
gNDELA: N-nitrosodiethanolamine
hHPLC-MS/MS: high-performance liquid chromatography coupled to tandem mass spectrometry
i1-OHP: 1-hydroxypyrene
j3-OHBaP: 3-hydroxybenzo(a)pyrene
kPAH: polycyclic aromatic hydrocarbons
lMDA: malondialdehyde
m8-OHdG: 8-Oxo-2'-deoxyguanosine
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Exposure Determinants
Exposure determinants are factors within the workplace that
contribute to increasing or reducing exposure concentrations
[14]. A questionnaire has been developed based on the literature
[1,15] and will be used by the occupational hygienists during
the field study.
Multidimensional Features of Exposure
Respirable Aerosol Exposure
The respirable particulate MWF mass fraction from personal
and stationary sampling will be determined following a reference
gravimetric method (INRS Metropol M-282). As a complement
to these measurements, the organic carbon content of the aerosol
collected on quartz filters will be determined using a specifically
modified thermal degradation method [16]. The MWF
concentration of the volatile organic fraction will be sampled
using a sorbent tube and analyzed chemically. The combination
of these measurements will be used to evaluate the overall
airborne MWF.
Oxidative Potential
Using the particulate oxidative potential as an additional metric
for evaluating possible toxic effects is a relatively new concept
and has rarely been used in occupational health studies. In our
study, the oxidative potential of the MWF themselves (new and
used) for the respirable fraction of the aerosol, as well as for
the gaseous phase, will be quantified. The oxidative potential
method used will be based on the ferrous oxidation-xylenol
orange method [17]. Briefly, MWF was sampled with a teflon
filter for the particulate phase followed by a XAD-2 sorbent
tube for the gaseous phase. An acidic solution of iron(II) (Fe2+)
with xylenol orange as the indicator and sorbitol as a catalyst
(ferrous ion oxidation [FOX] solution) was prepared. Oxidation
of Fe2+ to iron(III) (Fe3+) was followed by calorimetry using a
spectrometer. Increasing hydrogen peroxide (H2 O2) (aq) (0-10
uM) concentrations were used for calibration for the filters and
in dimethyl sulfoxide for the XAD-2 sorbent. The teflon filter
with the particulate MWF was punched and dropped into the
FOX solution, vortexed (1 min), and analyzed. The XAD-2
sorbent was desorbed with dichloromethane, evaporated,
resuspended in dimethyl sulfoxide, and analyzed.
Components in the Metalworking Fluid Aerosol
The metal content (eg, iron (Fe), copper (Cu), aluminum (Al),
zinc (Zn), manganese (Mn), antimony (Sb), cobalt (Co), nickel
(Ni), chromium (Cr), molybdenum (Mo), vanadium (V) and
titanium (Ti)) of the aerosol will be measured using stationary
samples with cellulose acetate filters, which will be mineralized
and analyzed using inductively coupled plasma atomic emission
spectroscopy (ICP-AES). Finally, aldehyde concentrations
including acetaldehyde and formaldehyde will be quantified.
Real Time Measurement of Ultrafine Particles
Exposure to ultrafine particles might be related to adverse health
effects, and ultrafine particles are present in MWF aerosol [2].
Particle number concentration of ultrafine particles will be
measured using a real time particle counter (DiscMini) in the
10-500 nm range. The particle size distribution between 0.25-32
µm will be determined with an optical particle counter (Grimm
Optical Particle Counter 1.109, 31 channels).
Exposure Biomarkers
EBC is an emerging technique that is simple, noninvasive and
allows scientists to study processes in the lungs [18]. The metal
concentrations in EBC (eg, Fe, Mn, Cr, Ni, Cu, Zn) will be
determined with an inductively coupled plasma mass
spectrometer (ICP-MS) using the analytical Totalquant
technique with external calibration [19,20].
We will measure the following urinary exposure biomarkers:
metals (27 metals), a nitrosamine (N-nitrosodiethanolamine
[NDELA]) and two PAH metabolites (1-hydroxypyrene
[1-OHP], a metabolite of pyrene, and 3-hydroxybenzo(a)pyrene
[3-OHBaP], a metabolite of benzo(a)pyrene). Metals will be
analyzed using ICP-MS [21], whereas the PAH metabolites will
be analyzed using high-performance liquid chromatography
with fluorescence detection (HPLC-Fluo) [22]. Finally, a more
sensitive method for analyzing urinary NDELA will be
developed based on high-performance liquid chromatography
coupled to tandem mass spectrometry (HPLC-MS/MS).
Inflammation and Oxidative or Nitrosative Stress
Biomarkers
Inflammation Biomarker
Nitric oxide is a biomarker of bronchial inflammation often
used [23] in an occupational context, and it is related to other
inflammation markers like nonspecific bronchial
hyperresponsiveness, a presumed precursor of asthma [24].
FeNO is a noninvasive and easy method of measuring nitric
oxide, with standardized commercial devices (Niox Vero)
available.
Oxidative or Nitrosative Stress Biomarkers in Exhaled
Breath Condensate
Following Basu [25]:
Isoprostanes, mainly 8-iso-PGF2αand 8-iso-PGE2,
possess potent biologic effects in a number of biologic
systems, and thus they may also serve as pathologic
mediators of oxidant stress through their
vasoconstrictive and inflammatory properties.
8-iso-prostaglandin F2α (8-iso-PGF2α) is a marker of a pathway
in the free radical lipid peroxidation mechanism, and therefore
fits our presumed mechanism shown in Figure 1.
Malondialdehyde (MDA) is another indirect marker of lipid
peroxidation, although it is considered less specific.
Concentrations of 8-Oxo-2'-deoxyguanosine (8-OHdG) are
considered a trace of a repairing/excretion mechanism for
oxidized guanine and are considered a measure of whole-body
oxidative stress. 8-isoprostane and 8-OHdG will be analyzed
following the publication by Syslova [26] using HPLC-MS/MS.
The same technique will be used for MDA analysis after a
derivatization step.
Nitrites and nitrates have previously been identified as pollutants
in aqueous MWF and are markers of nitrosative stress [27,28].
These two anions will be measured in EBC by ion
chromatography.
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Oxidative Stress Biomarkers in Urine
8-isoprostane, MDA and 8-OHdG will also be analyzed in the
urine using HPLC-MS/MS [29,30].
Genotoxic Effects and Respiratory Symptoms
Markers of Genotoxicity
Genotoxicity from MWF aerosol exposure will be assessed
using the buccal micronucleus cytome assay [31]. The presence
of micronuclei in buccal cells is considered a sign of damage
to the DNA and of chromosomal instability. Buccal cells will
be harvested from each participant. Using a microscope with
white and fluorescent light, the cells will be stained using
cytoplasmic and DNA staining and then 2000 cells will be
scored for the presence of micronuclei or nuclear buds. A
number of occupational exposures have given rise to excess
numbers of micronuclei [32].
Respiratory Symptoms
Symptoms of chronic bronchitis and asthma-like conditions
will be explored using the standardized Epidemiological study
on the Genetics and Environment of Asthma, bronchial
hyperresponsiveness and atopy (EGEA) questionnaire [33]. In
addition, the questionnaire will ask for cutaneous symptoms
(eczema or eczema-like symptoms).
Statistical Methods and Power
The statistical analysis will follow the presumed causal model
(Figure 2) and will be performed using the Stata (StataCorp LP,
College station, Texas) statistical software. The first analysis
will model the exposure measurements as a function of the
determinants using linear models, after suitable transformations
(logarithmic) if necessary. The exposure biomarkers in EBC
and urine will be modelled as a function of the exposure
measurements as well as possibly the exposure determinants.
These analyses will focus on the within-shift evolution of these
markers and will be based on mixed models. Measurements
below the limits of detection will be included using specific
models (random effect Tobit or Bayesian models) [34]. The
biomarkers of effect and the FeNO will be analyzed as a function
of the exposure measurements and determinants using similar
statistical models. Again, the focus will be on the within-shift
evolution but also on the evolution over the three days. The
effects from the circadian cycle will be controlled by the
simultaneous modelling of the nonexposed subjects. The
prevalence of symptoms and the frequency of micronuclei will
be analyzed using logistic regression as a function of the
exposed or nonexposed status and the chronic occupational
exposure that will be estimated from the job history and the
exposure determinants. Note that in the analysis of the frequency
of micronuclei, the number of collected cells per subject will
be included as an offset and that this analysis will account for
a possible overdispersion using a negative binomial regression.
Possible confounders such as smoking, age, sex and diet will
be accounted for in the different statistical analyses.
The study size was determined based on the longitudinal
evolution of FeNO and the comparison of the frequency of
micronuclei in two exposure groups. According to Bohadana
et al [35], a 10% increase of FeNO between 2 measurements
corresponds to an 80% power at a 5% significance level with a
sample of 30 subjects.
With respect to micronuclei, assuming a 0.74% [36] baseline
prevalence among controls, we have an 80% power at a 5%
significance level with two samples of 30 subjects. This allows
us to detect a 2.2 rate ratio between an exposed and a
nonexposed group assuming a 1.5 between-subject geometric
SD.
The rationale behind choosing the number of controls in a 1:2
ratio to exposed workers is to get equal sized exposure groups
between the aqueous exposed works, the straight oil exposed
workers, and the controls.
Study Organization
The present study is carried out by a consortium of three
organizations: (1) Team 1, the research team EA 4483 from the
IMPact de l’Environnement Chimique sur la Santé humaine
(IMPECS; Impact of the chemical environment on human
health) of the University of Lille in France; (2) Team 2,
Unisanté, the department of occupational and environmental
health from the University of Lausanne in Switzerland; and
finally (3) Team 3, the Institut National de Recherche et de
Sécurité (INRS; French National Institute for Research and
Safety) in France.
The study is coordinated by the INRS. A Consortium Agreement
specifying the legal, financial and scientific framework of the
cooperation regarding the present study was signed by the three
organizations on March 22, 2017.
Two parallel groups of scientists in Switzerland and France
with common operational procedures carry out the on-site data
collection. To minimize laboratory bias, most of the samples
are dispatched to and analyzed by one laboratory only. All
organic biomarkers in urine and EBC, as well as the micronuclei
frequency in buccal cells, will be analyzed by team 3. The metals
in EBC will be analyzed [14] by team 1. Team 2 will
characterize MWF aerosol for its oxidative potential, organic
carbon, nitrate, nitrite and aldehyde content as well as the
formate concentration in EBC. Both Team 2 and 3 will
determine the particulate exposure.
All electronic documents related to the study are deposited in
a structured, encrypted extranet located on a server of team 3.
The access to this extranet is strictly restricted to the study team
members by an individual password. Measurement data from
each lab will be deposited by the laboratories generating them.
All deposited data will be anonymous, and the rules for
generating the identification codes are defined by an operational
procedure. The data on the extranet will be saved daily and
backups will be kept in a separate building from the server. The
deposited data will be organized and prepared for data analysis
in the three months after collection by the same data manager,
who will provide regular feedback on the data collection.
Ethics and Data Dissemination
This study was approved by the ethical committee of the canton
Vaud, Switzerland (Commission cantonale d’éthique de la
recherche sur l’être humain CER-VD) on June 13, 2017, project
number 2017-00630, and by France (Comité de Protection des
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Personnes Sud-Est) on May 17, 2017, project number
17-02-EE-VD/OXIGENOCOM.
Several scientific, peer-reviewed publications are planned. The
first ones will correspond to the preparatory phases (eg, a
scientific article on the determination of biomarkers in EBC, a
paper on automatic versus human-based counting of micronuclei
in buccal cells). The other planned papers will respectively
correspond to the objectives described in the beginning of this
paper.
The ultimate objective is to develop relevant exposure reduction
strategies. The results will be published in a nonscientific format
and will be accessible by environmental health and safety
professionals.
Depending on the corresponding legal authorizations, parts or
all of the data will be deposited on a public data repository after
the final publications.
Results
Our study is organized into three partially overlapping periods.
The first period started October 2016 and ended December 2017
and was dedicated to: (1) obtaining the ethics committees’
consents; (2) writing and agreeing on operational procedures;
(3) setting up a study-specific data extranet; and (4) validating
analytical laboratory procedures.
The second period started with a pilot study conducted from
February 12, 2018 to Feb 14, 2018. The subsequent debriefing
led to minor adjustments of the daily organization of the data
collection. The data collection will end in June 2019. At the
time of writing, 100 subjects from 17 companies have been
included, comprising 29 control subjects. An additional three
companies will be included.
The third period consists of laboratory analysis, data
management, and data analysis. Written feedback will be
provided to participants and companies related to exposure.
Finally, a scientific report will be sent to the funding agency in
April 2020, and results will be published in peer-reviewed
journals.
Discussion
A strength of this project is its hypothesis driven and
multidisciplinary approach. First, the diversity of biomarkers
will shed some light on the physiopathological mechanisms.
Second, the extensive exposure assessment by occupational
hygienists will help in characterizing components that have a
short-term effect on the measured biomarkers. Finally, recording
exposure determinants will help with focusing the future
exposure preventions so that they have the greatest potential
impact on workers’ health.
One of the most interesting parameters is the oxidative potential
of the MWF aerosol. We hypothesize that oxidative potential
is a measure capturing the overall oxidative stress generated by
the aerosol and would thus be independent of the inert (or
nonreactive) constituents such as hydrocarbons. Thus, one of
the most interesting relationships to be explored is between
oxidative potential and the biomarkers of effect, in particular
the biomarkers of oxidative stress. In the words of Dr Ken
Donaldson [13]:
The measurement of the oxidative potential of ambient
particles would represent a more refined metric,
bringing it closer to the Biological Effect Dose with
anticipated improvements in risk management and
better associations with adverse health effects in
epidemiological studies.
Indeed, diverse approaches to assessing occupational exposure
give us the tools to characterize what might be the biological
effect dose.
Another strength is the noninvasive biomarker collection
approach. Respiratory symptoms and urinary biomarkers, and
to a lesser extent FeNO, are often used in occupational
epidemiology. EBC and micronuclei frequencies in buccal cells
are not routinely used yet; however, these biomarkers have
shown great promise in earlier work from our research group
[28,29,32,37,38]. Thus, the markers developed in this project
could potentially be used in routine monitoring of exposed
workers.
An important aspect of our study is that the relationships we
want to study are in two different time-frames. The relationships
between the exposure measurements and the evolution of the
biomarkers, be they measured in exhaled air, its condensate or
in urine, reflect short-term relationships. The second time frame
we consider is chronic. Neither the respiratory symptoms nor
the micronuclei frequency are assumed to vary in the 2 days of
data collection. These outcomes are therefore obtained only
once and reflect long-term effects. To some extent, we could
also consider the effect markers measured Monday morning as
possible long-term markers. However, when analyzing these
outcomes as a function of exposure, we have to consider
long-term exposure. The latter is necessarily less precise than
the measured exposure because it has to be assessed using the
jobs’ histories and tasks recorded in the questionnaire.
The constraints of our study protocol entailed a very intensive
field data collection from no more than 4 study subjects, with
4 researchers and technicians present in the companies over 4
days. This is the drawback of the very complete exposure
assessment, but also of the required participation time from
each worker, and finally of the required 2-day unexposed period
before inclusion. The total sample size is thus limited. To be
able to identify the exposure measurements that are closest to
the biological effective dose, it will be necessary to include
workers, and hence companies, with varied exposure
characteristics both qualitatively and in terms of exposure
concentrations. Bacterial contamination and endotoxin
measurements were not included due to limited resources.
Nevertheless, our protocol reflects a multidisciplinary approach
and allows small or very small companies to be included.
Consequently, the likelihood of having high exposure levels is
greater compared to large companies, which are the ones usually
explored in epidemiological studies.
Thus, the possible lack of power induced by the relatively small
number of included subjects will be compensated for by the
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large exposure variance when including both highly exposed
and less exposed workers. It is noteworthy that the repeated
measure design (five measurements per subject for urine and
two for EBC) will contribute to increase the power of detecting
short-term effects.
For outcomes collected only once reflecting long-term effects
(respiratory symptoms or micronuclei), the power will
correspondingly be lower, especially as the chronic exposure
estimate will be less precise and possibly affected by exposure
misclassification. As shown previously, one would need an odds
ratio greater than 2 to be able to detect such effects.
Related to statistical power is the issue of multiplicity. Indeed,
the number of outcomes will be quite large, so a number of
statistical models will be fitted to more or less the same data.
Thus, with the exception of the central hypothesis relating
oxidative potential measurements to oxidative stress, it will
certainly be safe to consider some analyses as exploratory or to
assign some multiplicity correction to any P value.
Conclusion
This study is unique, as it comprises human biological samples,
questionnaires, and MWF exposure measurement. The aim is
to develop preventative strategies based on exposure
determinants related to health outcomes. To achieve this goal,
this integrative multidisciplinary approach quantifies the
relationships between exposure determinants, exposure
measurements, biomarkers of exposure, biomarkers of effect,
and early effect outcomes.
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